Skip to main content

Dr. Oh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Oh's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Radiation Oncology, 2021 - 2025
  • NYU Long Island School of Medicine
    NYU Long Island School of MedicineInternship, Internal Medicine, 2020 - 2021
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2020, MD
  • Duke University
    Duke UniversityBS, Biology, High Distinction, 2011 - 2015

Awards, Honors, & Recognition

  • Memorial Sloan Kettering Summer Fellowship 2017

Publications & Presentations

Journal Articles

  • Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain- Dependent Manner in Mice  
    Daniel, AR, Lee, CL, Oh, P, Luo, L, Ma, Y, Kirsch, DG, Health Physics, 3/14/2020
  • Deletion of ATM in tumor but not endothelial cells improves radiation response in a primary mouse model of lung adenocarcinoma  
    Torok JA*, Oh P*, Castle, KD, Reinsvold M, Luo L, Lee CL, Kirsch DG, Cancer Research, 10/12/2018
  • Blocking cyclin-dependent kinase 4/6 during single dose vs. fractionated radiation therapy leads to opposite effects on acute gastrointestinal toxicity in mice  
    Lee CL, Oh P, Xu E, Ma Y, Kim Y, Daniel AR, Kirsch DG, International Journal of Radiation Oncology, Biology, Physics, 12/1/2018
  • Join now to see all

Abstracts/Posters

  • Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
    Oh P, Zhang M, Brady P, Sihag S, Molena D, Ilson DH, Janjigian YY, Ku GY, Wu AJ, Journal of Clinical Oncology, 2/26/2018
  • Impact of lung and heart dose on survival after radiotherapy for esophageal cancer
    Oh P, Zhang M, Brady P, Yorke E, Won E, Goodman KA, Wu AJ, Journal of Clinical Oncology, 2/26/2018
  • Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation
    Zhang M, Oh P, Brady P, Ilson DH, Janjigian Y,Ku G, Crane CH, Jackson A, International Journal of Radiation Oncology, Biology, Physics, 11/1/2018
  • Join now to see all

Press Mentions

  • Studies Explore Colon Tumor Sidedness, Lung Radiation Dose in Esophageal Cancer, Pembrolizumab in Liver Cancer, and More
    Studies Explore Colon Tumor Sidedness, Lung Radiation Dose in Esophageal Cancer, Pembrolizumab in Liver Cancer, and MoreMay 25th, 2020
  • In Esophageal Cancer, Lung Radiation Dose Affects Survival
    In Esophageal Cancer, Lung Radiation Dose Affects SurvivalMay 25th, 2020

Professional Memberships

  • American Society of Clinical Oncology
    Member
  • American Society for Radiation Oncology
    Member

Other Languages

  • Korean